Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38127827.
- Also identified by DOI 10.1200/PO.23.00299 and PMC identifier 10752463.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Complete response to Trametinib in a heavily-pretreated sarcoma: RAF1 as a predictor of MEKi Response
Medical subject headings
- Proto-Oncogene Proteins c-raf
- Fibrosarcoma